Gastroprotection in the treatment of erosive and ulcerative lesions of the stomach and small intestine-Reference-Cited by-同舟云学术

Gastroprotection in the treatment of erosive and ulcerative lesions of the stomach and small intestine

Published:2020-03-24 Issue:9 Volume: Page:17-26
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:jour

Author:

Plotnikova E. Yu.¹,Vologdanina L. G.²,Korotkevich A. G.³,Gracheva T. Yu.¹

Affiliation:

1. Federal State Budgetary Institution of Higher Education Kemerovo state medical University of the Ministry of health of Russia

2. Federal State Budgetary Institution of Higher Education Perm state medical University. academician E. A. Wagner, Ministry of health of Russia

3. State doctors improvement Institute of Novokuznetsk — a branch of FGBOU DPO RMAPO Ministry of health of Russia

Abstract

In article the reasons of erosive and ulcer injuries of a stomach, a small intestine are described. Special attention is paid to intake of nonsteroid anti-inflammatory medicines, microcirculation violation. Side effects of nonsteroid anti-inflammatory medicines and inhibitors of a proton pomp are in detail considered. Groups of patients with erosive and ulcer injuries of a stomach, small intestine with dyspepsia to which purpose of inhibitors of a proton pomp is not shown are allocated. Rebamipide can be appointed for prevention and treatment of erosive and ulcer injuries of a stomach, a small intestine with dyspepsia, both with inhibitors of a proton pomp, and in the form of monotherapy for the purpose of a gastroprotection to patients when use of inhibitors of a proton pomp is inexpedient. The gastroprotection algorithm depending on a condition of a gastric acid secretion of patients is offered.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference74 articles.

1. Solovyova, G. A. Erosion of a stomach there is a separate nosological form or universal reaction of a mucous membrane to damage? Internal medicine. 2007; 3: 96–99.

2. Zhurakhovskaya D. V., Loskutova E. E., Vinogradova I. A. The marketing analysis of the pharmaceutical market of nonsteroid anti-inflammatory medicines at the regional level. Modern problem sof science and education. 2014; 2. URL: http://science-education.ru/ru/article/view?id=12853

3. Nasonov E. L., Tsvetkova E. S., Balabanova R. M., etc. New aspects of anti-inflammatory therapy of rheumatic diseases: theoretical prerequisites and clinical application of a meloksikam. Wedge. medicine. 1996; 4: 4–8.

4. Karateev A. E., Nasonov E. L., Yakhno N. N., et al. Clinical recommendations «Rational use of nonsteroidanti-inflammatory medicines (NSAIDs) in clinical practice». Modern rheumatology. 2015;9(1): 4–23. https://doi.org/10.14412/1996–7012–2015–1–4–23.

5. Shchyokino E. G., Drogovoz S. M., Terrible V. V. NPVS – security concerns. Pharmacist. 2003; 4: 8–11.